Real World Evidence | pharmaphorum

Skip to main content

Tuesday 26 May 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Real World Evidence

Debates & Insight

IQVIA - RWE paper masthead 18

Sponsored

Standing on the cusp of something great: How real-world data...

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care

News

Roche Rituxan approval

Roche to buy health records firm Flatiron for $1.9bn

Flatiron has backers including Google parent Alphabet

Views & Analysis

Is the NHS ready to use real-world evidence to treat cancer?

Is NHS ready to use real-world data to find new therapies and ways to bring drugs to patients?

Views & Analysis

QuintilesIMS Banner 570x320

Utilise medtech for optimum care management

Medtech companies can provide the tools to empower patients and HCPs.

Views & Analysis

Law gavel 600

Healthcare evidence development: guilty until proven innocen...

Pharma must prepare its case meticulously to support its new drug applications.

Views & Analysis

Healthcare System Network as a Digital Technology Concept

Behind the buzz of real-world data and real-world evidence

Putting the who, where and why of real-world studies into context.

Load more results

Editor's Picks

GBL joins CVC in €10.7bn takeover bid for Recordati

After refusing to resign, CDER head Høeg is fired

As Ebola deaths climb, search begins for vaccine

NICE changes stance on Genmab's cervical cancer drug

Remepy's hybrid Parkinson's therapy poised for phase 3

Digital

pharmaphorum podcast Episode 261 - Kris Kaneta, Norstella

Trustworthy and novel AI in clinical trial planning, with Kr...

Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company